Illumina's divestiture of GRAIL boosts financials, while strong gross margins and DNA sequencing growth drive potential. See ...

Overview of Genomics in Cancer Care MarketThe global Genomics in Cancer Care Market is valued at USD 24.5 Billion in 2024 and ...

The Global Multi-omics Market comprising primarily Genomics, Transcriptomics, Proteomics, & Metabonomics is set to witness a ...

Plants produce a wide diversity of compounds. Broadly, these are separated into primary metabolites, which are necessary for ...

Market Growth Driven by Declining Sequencing Costs, Rising Prevalence of Genetic Disorders, Expanding Clinical Applications, and Technologica ...

Illumina Vice President of Bioinformatics James Han has been in the industry for decades—so he’s witnessed every stride the company has made in that time. “Illumina has worked tirelessly for the last ...

Business Strategy and Outlook Illumina continues to focus on transforming human health practices through its leadership of genomic sequencing and related applications.

The JAMA article, “Expanded newborn screening using genome sequencing for early actionable conditions,” highlights the feasibility and outcomes of expanding today’s standard newborn ...

SAN DIEGO-- (BUSINESS WIRE)--Inocras, an industry leader in whole genome sequencing and bioinformatics, released a new study highlighting the clinical validation of its CancerVision Target-Enhanced ...

Access free, up-to-date clinical references on whole-genome sequencing at Healio. Our content provides valuable clinical references to physicians.